Cargando…
Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system
The mammalian target of rapamycin (mTOR) inhibitors, a set of promising potential anti-cancer agents, has shown response variability among individuals. This study aimed to identify novel biomarkers and mechanisms that might influence the response to Rapamycin and Everolimus. Genome-wide association...
Autores principales: | Jiang, Jing, Fridley, Brooke L., Feng, Qiping, Abo, Ryan P., Brisbin, Abra, Batzler, Anthony, Jenkins, Gregory, Long, Pamela A., Wang, Liewei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757297/ https://www.ncbi.nlm.nih.gov/pubmed/24009623 http://dx.doi.org/10.3389/fgene.2013.00166 |
Ejemplares similares
-
Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study
por: Niu, Nifang, et al.
Publicado: (2012) -
Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines
por: Li, Liang, et al.
Publicado: (2014) -
Identification of genetic variants or genes that are associated with Homoharringtonine (HHT) response through a genome-wide association study in human lymphoblastoid cell lines (LCLs)
por: Tong, Yin, et al.
Publicado: (2015) -
Localization of Association Signal from Risk and Protective Variants in Sequencing Studies
por: Brisbin, Abra, et al.
Publicado: (2012) -
Gemcitabine and Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug Response Biomarkers
por: Li, Liang, et al.
Publicado: (2009)